Lifecare AS announced that the European Patent Office (EPO) has reported its intent to grant Lifecare a new patent. Lifecare will review the examining division's comments to the patent application and respond to the EPO for their final review and granting of the patent. Lifecare expects the EPO to announce the granting of patent within the next 6 months.

The present application relates to chemistry compositions, in special active fluid compositions which may be used in glucose sensor systems, for example a glucose sensor which relies on osmotic pressure as sensing principle. The chemistry composition is a fundamental addition to Lifecare's Sencell-technology and an important part for Lifecare's further development and commercialization. This new patent will strengthen Lifecare's technology protection until 2037.